Deep knowledge on
small-molecule drugs and
the 90,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
|Title:||Method of delivering powder transdermally with needless injector|
|Abstract:||A needleless syringe having a membrane which is ruptured by gas pressure to generate a supersonic gas flow in which particles containing a therapeutic agent are injected. This provides effective transdermal delivery of the therapeutic agent.|
|Inventor(s):||Bellhouse; Brian J. (Islip, GB2), Sarphie; David F. (Witney, GB2), Greenford; John C. (Abingdon, GB2)|
|Assignee:||Oxford Biosciences Limited (Oxford, GB2)|
Patent Claim Types:|
see list of patent claims
|Use; Delivery; Composition;|
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||1637173||May 21, 2014|
|World Intellectual Property Organization (WIPO)||9424263||Oct 27, 1994|
|European Patent Office||0734737||Oct 02, 1996|
|This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.